News &amp; Updates

Treatment with either nifedipine or labetalol is equally effective in controlling blood pressure (BP) among women with hypertension during pregnancy, with no adverse effects on perinatal outcomes, according to the Giant PANDA* trial presented at SMFM 2026.

Nifedipine as good as labetalol for managing hypertension during pregnancy

Finerenone shows promise for restoring fertility in premature ovarian insufficiency

In patients with premature ovarian insufficiency (POI), finerenone, a drug approved for slowing progressive kidney function decline associated with type 2 diabetes, can promote the development of follicles into mature oocytes yielding viable embryos, according to breakthrough findings by researchers from the University of Hong Kong (HKU).

Finerenone shows promise for restoring fertility in premature ovarian insufficiency

Lower 30-day reoperation rate with robotic arm–assisted total hip arthroplasty

Utilization of robotic arm–assisted primary total hip arthroplasty (rTHA) nearly doubled between 2019 and 2024 in public hospitals under the Hong Kong West Cluster (HKWC), and was associated with lower 30- and 90-day reoperation rates vs conventional THA (cTHA), researchers from the University of Hong Kong and Queen Mary Hospital have found.

Lower 30-day reoperation rate with robotic arm–assisted total hip arthroplasty

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use in patients with diabetes or heart diseases is not associated with increased risk of optic nerve or vision-threatening events, and plays a role in improving the long-term success rate of curative catheter ablation for atrial fibrillation (AF) in cardiac patients with obesity, researchers from the University of Hong Kong (HKU) have found.

Meta-analyses of global GLP-1 RA studies highlight safety and new potential role of GLP-1 RAs

Frontline tislelizumab plus chemo shows sustained survival advantage in NPC

In the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma (NPC), the combination of tislelizumab plus chemotherapy confers sustained survival benefit, according to 3-year data from the RATIONALE-309 trial.

Frontline tislelizumab plus chemo shows sustained survival advantage in NPC

GLP-1RA plus progestin combo fends off endometrial cancer risk

09 Mar 2026 by

Concurrent use of a glucagon-like peptide-1 receptor agonist (GLP-1RA) and progestins appears to protect against the risk of endometrial cancer in women with benign uterine pathology or endometrial hyperplasia, according to a real-world study.

GLP-1RA plus progestin combo fends off endometrial cancer risk

Frailty tied to higher risk of OA incidence, falls

Frailty appears predictive of an increased risk of osteoarthritis (OA) incidence and falls, as well as disease progression, in older adults, a study has shown. However, no association exists between frailty and joint replacement surgery-free time.

Frailty tied to higher risk of OA incidence, falls

Rheumatoid arthritis may induce ILD development

09 Mar 2026 by

Rheumatoid arthritis (RA) appears to contribute to the development of interstitial lung disease (ILD), as shown by genetic evidence from a Mendelian randomization (MR) study.

Rheumatoid arthritis may induce ILD development

09 Mar 2026

Cardiac screening detects condition tied to sudden cardiac death

A single cardiac screening has isolated a condition that appears to contribute to sudden cardiac arrest/death (SCA/SCD) in 0.3 percent of young individuals, reports a study.

Cardiac screening detects condition tied to sudden cardiac death